Dexamethasone for intracranial neurosurgery and anaesthesia

Journal of Clinical Neuroscience

Volumn 16, Issue 11, 2009, Pages 1389-1393

  Hockey, Brad ^a   Leslie, Kate ^a,b   Williams, Daryl ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Brain tumour; Cerebral oedema; Dexamethasone; Postoperative nausea and vomiting; Steroids

Indexed keywords

ANESTHETIC AGENT; AQUAPORIN; BUTYROPHENONE DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; DROPERIDOL; ETOPOSIDE; METOCLOPRAMIDE; MINERALOCORTICOID; ONDANSETRON; SEROTONIN 3 ANTAGONIST; TEMOZOLOMIDE; TIRILAZAD;

ADRENAL CORTEX INSUFFICIENCY; ANESTHESIA; BRAIN EDEMA; BRAIN SURGERY; BRAIN TUMOR; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DOSE COMPARISON; DRUG HALF LIFE; DRUG MECHANISM; DRUG PROTEIN BINDING; EUPHORIA; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GLIOBLASTOMA; GLIOMA; HEADACHE; HUMAN; HYPERGLYCEMIA; INTRACRANIAL HYPERTENSION; IONIZING RADIATION; MOON FACE; NEUROPATHIC PAIN; NEUROSURGERY; NONHUMAN; OSTEOPENIA; PAIN; POSTOPERATIVE NAUSEA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; REVIEW; SIDE EFFECT; SKIN FRAGILITY; STRIA; SUBARACHNOID HEMORRHAGE; TRANSSPHENOIDAL SURGERY; TRAUMATIC BRAIN INJURY; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANESTHESIA; ANTIEMETICS; BRAIN DISEASES; DEXAMETHASONE; HISTORY, 20TH CENTURY; HUMANS; NEUROSURGERY;

EID: 70449522066     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.03.007     Document Type: Review

References (50)

1. McClelland S., and Long D.M. Genesis of the use of corticosteroids in the treatment and prevention of brain edema. Neurosurgery 62 (2008) 965-968
2. Allen K. Dexamethasone: an all purpose agent?. Australasian Anaesthesia (2007) 65-70
3. Werner M.U., Lassen B., and Kehlet H. Analgesic effects of dexamethasone in burn injury. Reg Anesth Pain Med 27 (2002) 254-260
4. Johansson A., Hao J., and Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand 34 (1990) 335-338
5. Mims Online. DBL Dexamethasone sodium phosphate injection. .
6. Galicich J.H., and French L.A. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am J Pract Dig Treat 12 (1961) 169-174
7. Tatter S.B. Recurrent malignant glioma in adults. Curr Treat Options Oncol 3 (2002) 509-524
8. Kaal E.C., and Vecht C.J. The management of brain edema in brain tumors. Curr Opin Oncol 16 (2004) 593-600
9. Vecht C.J., Hovestadt A., Verbiest H.B.C., et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors. A randomized study of doses of 4, 8, and 16 mg per day. Neurology 44 (1994) 675-678
10. Nahaczewski A.E., Fowler S.B., and Hariharan S. Dexamethasone therapy in patients with brain tumors-A focus on tapering. J Neurosci Nurs 36 (2004) 340-343
11. Leenders K.L., Beaney R.P., Brooks D.J., et al. Dexamethasone treatment of brain tumor patients. Effects on regional cerebral blood flow, blood volume and oxygen utilization. Neurology 36 (1985) 1400-1403
12. Heiss J.D., Papavassiliou E., Merrill M.J., et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. J Clin Invest 98 (1996) 1400-1408
13. Quarles C.C., Krouwer H.G., Rand S.D., et al. Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters. Technol Cancer Res Treat 4 (2005) 245-249
14. Badruddoja M.A., Krouwer H.G., Rand S.D., et al. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neurosurgery 63 (2008) 286-291
15. Villeneuve J., Galarneau H., Beaudet M.J., et al. Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment. Brain Pathol 18 (2008) 401-414
16. Griesdale D.E.G., and Honey C.J. Aquaporins and brain edema. Surg Neurol 61 (2004) 418-421
17. King L.S., Nielsen S., and Agre P. Aquaporin-1 water channel protein in lung. J Clin Invest 97 (1996) 2183-2191
18. McGirt M.J., Chaichana K.L., Gathinji M., et al. Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. Neurosurgery 63 (2008) 286-291
19. Lukins M.B., and Manninen P.H. Hyperglycaemia in patients administered dexamethasone for craniotomy. Anesth Analg 100 (2005) 1129-1133
20. Das A., Banik N.L., Patel S.J., et al. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 3 (2004) 36-45
21. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
22. Asadullah K., Woiciechowsky C., Döcke W.D., et al. Very low monocytic HLA-DR expression indicates high risk of infection - immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 2 (1995) 184-190
23. Pilkington G.J., Parker K., and Murray S.A. Approaches to mitochondrially mediated cancer therapy. Semin Cancer Biol 18 (2008) 226-235
24. Fukuda S., and Warner D.S. Cerebral protection. Br J Anaesth 99 (2007) 10-17
25. Longstreth Jr. W.T., and Inui T.S. High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest. Ann Neurol 15 (1984) 59-63
26. Longstreth Jr. W.T., Diehr P., Cobb L.A., et al. Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation. Neurology 36 (1986) 1186-1191
27. Baird T.A., Parsons M.W., Phanh T., et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34 (2003) 2208-2214
28. Bilotta F., Pellicciotta D., Maurizio C., et al. Intensive insulin infusion as a neuroprotective therapy after intracranial aneurysm surgery: a randomised prospective pilot trial [abstract]. J Neurosurg Anesthesiol 15 (2003) 373
29. Jelluma N., Yang X., Stokoe D., et al. Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes. Mol Cancer Res 4 (2006) 319-330
30. Suba Z., and Ujpál M. Correlations of insulin resistance and neoplasms [abstract]. Magy Onkol 50 (2006) 127-135
31. Dempsey R.J., Baskaya M.K., Combs D.J., et al. Effect of hyperglycemia on reperfusion-associated recovery of intracellular pH and high energy phosphates after transient cerebral ischemia in gerbils. Neurol Res 18 (1996) 546-552
32. Bhardwaj A., Ellegala D.B., and Kirsch J.R. Acute brain and spinal cord injury: evolving paradigms and management. 1st ed. (2008), Informa Health Care p. 308
33. Schurkamper M., Medele R., Zausinger S., et al. Dexamethasone in the treatment of subarachnoid hemorrhage revisited: a comparative analysis of the effect of the total dose on complications and outcome. J Cin Neurosci 11 (2004) 20-24
34. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 3rd ed. London: The Royal College of Physicians; 2008.
35. Alderson P, Roberts IG. Corticosteroids for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD000196. DOI: 10.1002/14651858.CD000196.pub2.
36. Chen J.C.T., Amar A.P., Choi S., et al. Trans-sphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98 (2003) 967-973
37. Flynn B.C., and Nemergut E.C. Postoperative nausea and vomiting and pain after trans-sphenoidal surgery: a review of 877 patients. Anesth Analg 103 (2006) 162-167
38. Leslie K., Troedel S., Irwin K., et al. Quality of recovery from anesthesia in neurosurgical patients. Anesthesiology 99 (2003) 1158-1165
39. Myles P.S., Williams D.L., Hendrata M., et al. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10811 patients. Br J Anaesth 84 (2000) 6-10
40. Carlisle J., and Stevenson C.A. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 3 (2006) CD004125
41. Habib A.S., and Gan T.J. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anaesth 51 (2004) 326-341
42. Lee Y., Lai H.Y., Lin P.C., et al. A dose ranging study of dexamethasone for preventing patient-controlled analgesia-related nausea and vomiting: a comparison of droperidol with saline. Anesth Analg 98 (2004) 1066-1071
43. Apfel C.C., Korttila K., Abdalla M., et al. IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 350 (2004) 2441-2451
44. Kathirvel S., Dash H.H., Bhatia A., et al. Effect of prophylactic ondansetron on postoperative nausea and vomiting after elective craniotomy. J Neurosurg Anesth 13 (2001) 207-212
45. Neff S.P., Stapelberg E., and Warmington A. Excruciating perineal pain after intravenous dexamethasone. Anaesth Intensive Care 30 (2002) 370-371
46. Perron G., Dolbec P., Germain J., et al. Perineal pruritus after IV dexamethasone administration (letter). Can J Anesth 50 (2003) 749-750
47. Hans P., Vanthuyne A., Dewandre P.Y., et al. Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients undergoing abdominal surgery. Br J Anaesth 97 (2006) 164-170
48. McKean S., Kochilas X., Kelleher R., et al. Use of intravenous steroids at induction of anaesthesia for adult tonsillectomy to reduce postoperative nausea and vomiting and pain: a double-blind randomized controlled trial. Clin Otolaryngol 31 (2006) 36-40
49. Knotkova H., and Pappagallo M. Adjuvant analgesics. Anesth Clin 25 (2007) 775-786
50. Levy M.H. Pharmacologic treatment of cancer pain. N Engl J Med 335 (1996) 1124-1132